Goldman Sachs Sticks to Its Hold Rating for Centene (CNC)

In a report released today, Nathan Rich from Goldman Sachs maintained a Hold rating on Centene (CNC – Research Report). The company’s shares closed today at $74.00.

According to TipRanks, Rich is a 3-star analyst with an average return of 1.2% and a 47.97% success rate. Rich covers the Healthcare sector, focusing on stocks such as Humana, Align Tech, and Centene.

Currently, the analyst consensus on Centene is a Moderate Buy with an average price target of $91.10.

CNC market cap is currently $40.56B and has a P/E ratio of 15.44.

Based on the recent corporate insider activity of 64 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of CNC in relation to earlier this year. Most recently, in February 2024, Lori Jean Robinson, a Director at CNC sold 10,000.00 shares for a total of $774,100.00.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Centene (CNC) Company Description:

Centene Corporation is a diversified healthcare company that primarily engages in providing programs and services to the government sponsored healthcare programs. The company is also engaged in providing education and outreach programs to assist members in accessing quality and appropriate healthcare services.